These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7927856)

  • 1. Application of USC*PACK clinical programs to vancomycin in neutropenic patients.
    Kergueris MF; Le Normand Y; Jahan P; Milpied N
    Int J Biomed Comput; 1994 Jun; 36(1-2):163-5. PubMed ID: 7927856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic parameters of vancomycin for therapeutic regimens in neutropenic adult patients.
    Le Normand Y; Milpied N; Kergueris MF; Harousseau JL
    Int J Biomed Comput; 1994 Jun; 36(1-2):121-5. PubMed ID: 7927850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of vancomycin clearance and creatinine clearance: unreliability for predicting initial dosing in neutropenic haematological patients.
    Soto J; Alsar MJ; Chantal P; Sacristán JA
    J Antimicrob Chemother; 1993 Dec; 32(6):920-2. PubMed ID: 8144443
    [No Abstract]   [Full Text] [Related]  

  • 4. Vancomycin dosing in neutropenic patients.
    Haeseker MB; Croes S; Neef C; Bruggeman CA; Stolk LM; Verbon A
    PLoS One; 2014; 9(11):e112008. PubMed ID: 25390637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population.
    Jarkowski A; Forrest A; Sweeney RP; Tan W; Segal BH; Almyroudis N; Wang ES; Wetzler M
    J Oncol Pharm Pract; 2012 Mar; 18(1):91-6. PubMed ID: 21521799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients.
    Polard E; Le Bouquin V; Le Corre P; Kérebel C; Trout H; Feuillu A; Le Verge R; Mallédant Y
    Ther Drug Monit; 1999 Aug; 21(4):395-403. PubMed ID: 10442692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased vancomycin clearance in patients with congestive heart failure.
    Shimamoto Y; Fukuda T; Tominari S; Fukumoto K; Ueno K; Dong M; Tanaka K; Shirasaka T; Komori K
    Eur J Clin Pharmacol; 2013 Mar; 69(3):449-57. PubMed ID: 22791272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of serum vancomycin concentrations using one-, two- and three-compartment models with implemented population pharmacokinetic parameters and with the Bayesian method.
    Wu G; Furlanut M
    J Pharm Pharmacol; 1998 Aug; 50(8):851-6. PubMed ID: 9751448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmented Renal Clearance in Patients With Febrile Neutropenia is Associated With Increased Risk for Subtherapeutic Concentrations of Vancomycin.
    Hirai K; Ishii H; Shimoshikiryo T; Shimomura T; Tsuji D; Inoue K; Kadoiri T; Itoh K
    Ther Drug Monit; 2016 Dec; 38(6):706-710. PubMed ID: 27681114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaco-informatics: more precise drug therapy from 'multiple model' (MM) adaptive control regimens: evaluation with simulated vancomycin therapy.
    Jelliffe RW; Bayard D; Schumitzky A; Milman M; Van Guilder M
    Medinfo; 1995; 8 Pt 2():1106-10. PubMed ID: 8591381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Initial dosage of vancomycin in neutropenic hematologic patients].
    Soto J; Alsar MJ; Sacristán JA
    Sangre (Barc); 1992 Jun; 37(3):181-4. PubMed ID: 1440095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot Study of a Bayesian Approach To Estimate Vancomycin Exposure in Obese Patients with Limited Pharmacokinetic Sampling.
    Carreno JJ; Lomaestro B; Tietjan J; Lodise TP
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer dosing program for the initiation of vancomycin therapy.
    Ito MK; Duren LL; Simonian JS; Dreyfus-Vigil SD; Cookson TL
    Clin Pharm; 1993 Feb; 12(2):126-30. PubMed ID: 8453861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and dosage regimens of amikacin in intensive care unit patients.
    Debord J; Voultoury JC; Lachatre G; Favereau JP; Gay R
    Int J Biomed Comput; 1994 Jun; 36(1-2):135-7. PubMed ID: 7927853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
    Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
    Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive performance of two software packages (USC*PACK PC and Abbott PKS system) for the individualization of amikacin dosage in intensive care unit patients.
    Gauthier T; Lacarelle B; Marre F; Villard PH; Catalin J; Durand A
    Int J Biomed Comput; 1994 Jun; 36(1-2):131-4. PubMed ID: 7927852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of pharmacokinetic parameters of amikacin in a group of neutropenic patients in onco-hematology].
    Pivot-Dumarest C; Deweerdt C; Troncy J; Sorensen P; Roux D; Maire P
    Pathol Biol (Paris); 1996 Apr; 44(4):299-305. PubMed ID: 8763595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
    Yang RH; Rong XZ; Hua R; Zhang T
    Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic analysis of vancomycin in patients with gram-positive infections and the influence of infectious disease type.
    Yamamoto M; Kuzuya T; Baba H; Yamada K; Nabeshima T
    J Clin Pharm Ther; 2009 Aug; 34(4):473-83. PubMed ID: 19583681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of vancomycin in adult cystic fibrosis patients.
    Pleasants RA; Michalets EL; Williams DM; Samuelson WM; Rehm JR; Knowles MR
    Antimicrob Agents Chemother; 1996 Jan; 40(1):186-90. PubMed ID: 8787903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.